TheraRadar
← Back
Data updated: Jul 17, 2026

FIRST TIME US GENERICS LLC

Pharma
Pharmaceuticals

FIRST TIME US GENERICS LLC is a pharmaceutical company with 0 FDA-approved products.

-
Since
0
Drugs
-
Trials
0
New Drugs (2yr)

FIRST TIME US GENERICS LLC's Key Drugs

FIRST TIME US GENERICS LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

FIRST TIME US GENERICS LLC's Recent FDA Approvals

New NDA/BLA approvals for FIRST TIME US GENERICS LLC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

FIRST TIME US GENERICS LLC's Therapeutic Areas

Disease areas where FIRST TIME US GENERICS LLC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

FIRST TIME US GENERICS LLC Pipeline Snapshot

Active clinical trials for FIRST TIME US GENERICS LLC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling